Cure8 research brief
Itch is a frequent, often severe symptom in PSC that is linked to liver disease severity and worse quality of life. Recognizing and measuring pruritus matters because it significantly affects daily functioning and may need targeted management.
Patients with PSC (including those with IBD), hepatologists and gastroenterologists, symptom-management clinicians, and researchers focused on PSC and pruritus.
This study reports that pruritus (itch) is common and persistent among people with primary sclerosing cholangitis (PSC).
Using validated itch scales, about one-quarter reported moderate-to-severe itch over the prior week and nearly 40% over the prior 6 months; itch severity was linked to liver disease markers (cirrhosis, alkaline phosphatase, bilirubin, lower albumin) and to worse quality-of-life scores.
Among participants who also had inflammatory bowel disease, worse colitis activity was associated with more severe itch. The study followed patients for up to 6 months and found that itching often fluctuated, with most who reported moderate-to-severe itch over 6 months experiencing severe episodes at least once.
The authors conclude that pruritus in PSC is clinically meaningful and variable over time, and they highlight the need for standardized assessment and better treatments. This brief summarizes the study abstract published in Alimentary Pharmacology & Therapeutics and does not represent a review of the full article beyond the provided abstract.
The source is an abstract from Alimentary Pharmacology & Therapeutics on PubMed; findings are based on patient-reported scales and associations with clinical labs over up to 6 months of follow-up. This brief is grounded in the provided abstract and does not substitute for full-text review.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
PSC is rare in the general population but substantially more common in people with IBD, particularly ulcerative colitis, and it raises long-term hepatobiliary risks including cholangiocarcinoma—so knowing how often PSC...
PSC occurring with IBD changes cancer risk and surveillance needs: patients can have extensive but asymptomatic colitis and a higher colorectal and biliary cancer risk. The review outlines gaps in diagnosis, monitoring,...
Skin disease (hidradenitis suppurativa) may be more common in people with IBD—particularly Crohn disease—and could be linked with more severe intestinal complications. Awareness can prompt coordinated care between...
